Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synflorix Booster and Catch-up Study in Nigerian Children
NCT01153893Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2010
- Primary completion
- Feb 2011
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 3, open-label trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection (2 arms), sponsored by GSK. Primary endpoint: Number of Subjects Reporting Grade 3 Symptoms (Solicited and Unsolicited). Started Oct 2010; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01153893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01153893.